Navigation Links
Columbia River Resources Inc subsidiary, Traxxec Ltd, reports coverage of its technology at Interpack 2008 (Pink Sheets OTC - CRVR.pk)
Date:4/29/2008

NEWCASTLE UNDER LYME, UK, April 29 /PRNewswire-FirstCall/ - Traxxec Ltd, the UK subsidiary of Columbia River Resources Inc (Pink Sheets OTC - CRVR.pk), today announces that, in line with the licence agreement with Rexam plc, its technology is being presented at the Interpack conference and trade show in Dusseldorf, 24-30 April.

Major pharmaceutical and packaging companies will be present at this meeting giving the Traxxec RFID bottle coverage in both the US and Europe, markets with direct exposure to the major global packaging buyers.

As outlined below in Rexam's latest news, the Traxxec developed bottle will be presented as part of the healthcare product range.

Rexam to showcase innovation and consumer insights at Interpack 2008

Rexam, the world's leading beverage can maker and a leading global manufacturer of rigid plastic packaging, will highlight key innovations at Interpack in Dusseldorf, 24-30 April 2008, where it will showcase its latest innovative products from across the company.

Visitors to Interpack 2008 will have a rare opportunity to see the number two global consumer packaging company's full product range including its latest offerings for the Personal Care, Food, Healthcare and Beverage markets.

Rexam will demonstrate its understanding of trends affecting consumer values, attitudes and behavior, and how they impact innovation now and in the future. Rexam's stand (Hall 10, stand B22/C21) will focus on three major trends influencing the packaging industry today: Senior Friendly; Environmentally Friendly and Nomadism (on-the-go).

To communicate the relevance of these trends to visitors, Rexam will be hosting an intimate, by-appointment-only "Be Inspired Innovation Theatre" on its stand. Here, Rexam will be unveiling its latest thinking around key industry trends and innovations.

"This environment will place our packaging solutions in a special context, so that customers can truly see what's possible with Rexam," said a spokesman for Rexam.

Traxxec's CEO Amy Scopes comments "This is extremely positive and up-beat news for the company providing early exposure of both the Company and its developed product to target customers in line with our projected business model".

For more information please visit http://www.Traxxec.com

NOTES:

1. Traxxec's technology has worldwide patent protection

2. As part of the proposed business model and product development

process the founders of Traxxec, funded by the pharmaceutical

industry, have undertaken through two pilot installations a

feasibility study on product design and as a consequence of this

work, supplied a fully commercial product for evaluation purposes to

a client with an annual buying capacity of 20,000,000 bottles.

Traxxec Ltd was incorporated specifically to exploit this IP

commercially. Since its incorporation, Traxxec Ltd has also supplied

commercial product for a live, current phase III study in the US. As

part of the technology transfer to Rexam Pharma, commercial product

was successfully manufactured by them and supported by systems

software provided by Traxxec Ltd. To date 21,000 units have been

delivered.

3. The result of the comprehensive testing led to the decision by Rexam

to enter into licensing negotiation and complete the 15 year royalty

licence agreement. The market sector for pharmaceutical product is in

excess of 20 billion US dollars and bottles represent 30% of the

available market per annum.

For further information on Traxxec's developments within the RFID/packaging industry please visit the articles below.

http://www.in-pharmatechnologist.com/news/ng.asp?id=73668-

rexam-traxxec-rfid-fda-pill-container

http://www.modplas.com/inc/mparticle.php?section=E-

Weekly&thefilename=eweekly07012007_22

http://www.ceepackaging.com/2007/01/24/rfid-solution-for-containers/

http://rfid.idtechex.com/knowledgebase/en/sectionintro.asp?sectionid

=115 http://www.packaging-gateway.com/features/feature1317/

This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Traxxec Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NewYork-Presbyterian/Columbia physician-scientists present at ACCs 57th Annual Scientific Session
2. Columbia University Medical Center/NYPH receive $28 million donation toward curing diabetes
3. Columbia Center for Childrens Environmental Health receives NIEHS grant to study asthma
4. University of British Columbia Research Shows Health Benefits of GameBike (TM)
5. Columbiana County Board of MR/DD Chooses Q Continuum(TM) System
6. HHS Secretary Leavitt to Address Columbia School of International and Public Affairs
7. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
8. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
9. Four Rivers Software Systems Delivers TMS WorkGroup 2008.3.3
10. Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area
11. New Medicare Equipment Bidding Program for Riverside, California Area is Rife with Errors, Says the American Association for Homecare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: